QIAGEN Acquires Genoox for $70M to Expand AI-Powered Genomic Interpretation Portfolio

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insigh...

May 13, 2025 | Tuesday | News
Can-Fite Secures $175M to Advance Oral A3AR Therapies into Phase III for Liver Cancer and Psoriasis

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory diseases, toda...

May 06, 2025 | Tuesday | News
New Diagnostics for Schistosomiasis Receive JPY 780 Million Investment to Improve Global Health

Schistosomiasis is one of 21 NTDs that affects approximately 250 million people worldwide, with 90% of cases occurring in Africa. People become infect...

March 19, 2025 | Wednesday | News
GHIT Fund Marks Milestone with First Administration of Arpraziquantel to Preschool Children in Uganda

The Global Health Innovative Technology (GHIT) Fund is announcing a significant milestone: the first administration of arpraziquantel to preschool-aged chi...

March 05, 2025 | Wednesday | News
M42 and Uzbekistan’s Ministry of Health Partner to Advance Genomic Research and Diversity

In a sign of its ambition to expand its foothold in genomics and grow its contribution to global genomics diversity, M42 and Uzbekistan’s Ministry ...

January 29, 2025 | Wednesday | News
Beckman Coulter Life Sciences and Indiana University Secure $2.5M Grant to Boost Leukemia and Lymphoma Testing in Kenya

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, along with the Indiana University School of Medicine, have been a...

January 22, 2025 | Wednesday | News
PharmAla Biotech Partners with Merhavim Mental Health Centre for Groundbreaking MDMA-Assisted Psychotherapy Trial

PharmAla Biotech Holdings Inc.  a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel deriv...

January 21, 2025 | Tuesday | News
SciSparc Secures Renewal to Advance SCI-210 Clinical Trial for Autism Spectrum Disorder

SciSparc, a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, to...

January 02, 2025 | Thursday | News
Saudi Arabia’s KFSHRC Launches MENA’s First Advanced Hematology Diagnostics Laboratory

King Faisal Specialist Hospital & Research Centre (KFSHRC) inaugurated the Advanced Hematology Diagnostics Laboratory under the patronage of Deputy C...

December 20, 2024 | Friday | News
Grégory Garnier: "Middle East's M&A Surge Positions the Region as a Global Investment Powerhouse"

Global M&A Deal Value Poised to Hit $3.5 Trillion in 2024 New research from Bain & Company reveals a 15% growth in global M&A activity, with t...

December 18, 2024 | Wednesday | News
Pharma’s Next Frontier: Middle East Manufacturing Boom as Saudi Arabia Hosts Inaugural CPHI Event

    Efforts to build a new manufacturing, biomanufacturing and R&D hub in Saudi Arabia and across the wider Middle East are accelerating as...

December 11, 2024 | Wednesday | News
Beyond Cancer Receives Israeli Ministry of Health Approval for Phase 1b Trial of LV UNO in Combination with Anti-PD-1 Therapy

Beyond Cancer, Ltd., a clinical-stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors...

December 04, 2024 | Wednesday | News
NurExone Gains EMA Orphan Designation for ExoPTEN, Advancing Spinal Cord Injury Therapy Across Europe

NurExone Biologic Inc.  a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce that the European Medici...

November 14, 2024 | Thursday | News
Theriva Biologics Named Finalist for Merck KGaA’s EMEA Advance Biotech Grant

Theriva™ Biologics (NYSE American: TOVX), a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancer and relate...

November 04, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close